Logo image of DTEA.CA

DAVIDSTEA INC (DTEA.CA) Stock Fundamental Analysis

TSX-V:DTEA - TSX Venture Exchange - CA2386611024 - Common Stock - Currency: CAD

1  +0.04 (+4.17%)

Fundamental Rating

1

DTEA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 15 industry peers in the Specialty Retail industry. Both the profitability and financial health of DTEA have multiple concerns. DTEA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

DTEA had negative earnings in the past year.
In the past year DTEA had a positive cash flow from operations.
DTEA had negative earnings in 4 of the past 5 years.
In multiple years DTEA reported negative operating cash flow during the last 5 years.
DTEA.CA Yearly Net Income VS EBIT VS OCF VS FCFDTEA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

With a Return On Assets value of -21.58%, DTEA is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -60.31%, DTEA is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
ROA -21.58%
ROE -60.31%
ROIC N/A
ROA(3y)14.67%
ROA(5y)-9.43%
ROE(3y)18.19%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DTEA.CA Yearly ROA, ROE, ROICDTEA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

DTEA has a Gross Margin of 45.54%. This is in the better half of the industry: DTEA outperforms 78.57% of its industry peers.
DTEA's Gross Margin has been stable in the last couple of years.
DTEA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5YN/A
DTEA.CA Yearly Profit, Operating, Gross MarginsDTEA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

2

2. Health

2.1 Basic Checks

DTEA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DTEA has been increased compared to 1 year ago.
DTEA has a worse debt/assets ratio than last year.
DTEA.CA Yearly Shares OutstandingDTEA.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
DTEA.CA Yearly Total Debt VS Total AssetsDTEA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

DTEA has an Altman-Z score of -1.57. This is a bad value and indicates that DTEA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.57, DTEA is doing worse than 85.71% of the companies in the same industry.
DTEA has a Debt/Equity ratio of 0.62. This is a neutral value indicating DTEA is somewhat dependend on debt financing.
DTEA has a Debt to Equity ratio (0.62) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Altman-Z -1.57
ROIC/WACCN/A
WACC9.02%
DTEA.CA Yearly LT Debt VS Equity VS FCFDTEA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

DTEA has a Current Ratio of 1.56. This is a normal value and indicates that DTEA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.56, DTEA belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
DTEA has a Quick Ratio of 1.56. This is a bad value and indicates that DTEA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.71, DTEA perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 0.71
DTEA.CA Yearly Current Assets VS Current LiabilitesDTEA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

0

3. Growth

3.1 Past

DTEA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.68%.
DTEA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -26.96%.
DTEA shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -20.72% yearly.
EPS 1Y (TTM)7.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.05%
Revenue 1Y (TTM)-26.96%
Revenue growth 3Y-20.72%
Revenue growth 5YN/A
Sales Q2Q%15.59%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DTEA.CA Yearly Revenue VS EstimatesDTEA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2020 2021 2022 2023 2024 50M 100M 150M 200M
DTEA.CA Yearly EPS VS EstimatesDTEA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2022 2023 2024 0 0.1 -0.1 0.2 0.3

0

4. Valuation

4.1 Price/Earnings Ratio

DTEA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DTEA.CA Price Earnings VS Forward Price EarningsDTEA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DTEA.CA Per share dataDTEA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

DTEA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DAVIDSTEA INC

TSX-V:DTEA (2/21/2025, 7:00:00 PM)

1

+0.04 (+4.17%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)12-10 2024-12-10/bmo
Earnings (Next)04-30 2025-04-30
Inst Owners11.36%
Inst Owner ChangeN/A
Ins Owners2.95%
Ins Owner ChangeN/A
Market Cap26.62M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.42
P/FCF N/A
P/OCF 30.28
P/B 1.68
P/tB 1.68
EV/EBITDA N/A
EPS(TTM)-0.36
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.03
OCFY3.3%
SpS2.36
BVpS0.6
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.58%
ROE -60.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.54%
FCFM N/A
ROA(3y)14.67%
ROA(5y)-9.43%
ROE(3y)18.19%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5YN/A
F-Score4
Asset Turnover1.42
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 52.52%
Cap/Sales 2.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 0.71
Altman-Z -1.57
F-Score4
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)21.83%
Cap/Depr(5y)19.28%
Cap/Sales(3y)1.25%
Cap/Sales(5y)1.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.05%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-26.96%
Revenue growth 3Y-20.72%
Revenue growth 5YN/A
Sales Q2Q%15.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1984.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1045.29%
OCF growth 3YN/A
OCF growth 5YN/A